The master supplier directory

This is the full list of organisations we hold evidence for, in one table per category, with a jump list at the top. Forty-one organisations, of which eleven publish a price you can read without speaking to anyone, and two have exited the market entirely. The exits are listed alongside the live suppliers, because knowing who has stopped is worth as much to a buyer as knowing who has started, and no vendor-maintained list ever records it.

Read the three disclaimers before the tables, because they change what the tables mean.

Listing is not endorsement. An organisation appears here because we found evidence it supplies something in a category we broker. It does not appear because it is good, and it does not appear because it paid.

We are not paid for placement. There is no listing fee, no sponsored row, no preferential ordering and no affiliate arrangement behind any link on this page. We take a fee from buyers for sourcing work, and that fee does not change based on which supplier wins. We do not manufacture anything, so we are not competing with anyone in this table either.

We have not verified every organisation to the same depth. The evidence column tells you which is which, honestly. Live-verified means we queried the vendor’s own storefront or page and read the value on the date shown. Captured means we read it on the date shown but a re-fetch was subsequently blocked. Vendor page means the claim is the vendor’s own published description, taken at face value. Unverified means the organisation blocked automated retrieval, or the only source is a third party, and you should treat the row as a lead rather than a fact.

Jump to a category

• Human and iPSC-derived cells — 12 organisations
• Ready-to-use 3D tissue models — 7 organisations
• Engineered contractile tissue — 5 organisations
• Neural cultures and electrode interfaces — 6 organisations
• Culture devices, microfluidics and instruments — 8 organisations
• Native and primary tissue to specification — 6 organisations
• Contract cell culture and manufacturing — 7 organisations
• QC, characterisation and acceptance testing — 5 organisations
• Cold chain and logistics — 3 organisations
• Exited, closed or discontinued — 2 organisations

Several organisations appear in more than one category, because several of them genuinely operate in more than one. eNUVIO sells a device, sells a custom fabrication service and sells contract culture; it is listed under each, with the relevant line of business named in the row.

Category directories

This page is the master index. Seven categories have their own directory with the specification-level columns that decide a purchase — passage numbers, licence obligations, guaranteed doublings, published fees at both academic and commercial tiers — which are too detailed to carry here.

Human and iPSC-derived cells

This is the most transparent corner of the market and the only category where a majority of suppliers publish list prices. For the neuron subset specifically — subtypes, purity specifications, published MEA data, donor provenance and licence posture — the deep dive is iPSC neuron suppliers, and it is not repeated here.

Twelve organisations, eight of them with a price you can read today. That is unusual, and it is worth understanding why: cryopreserved cells are a shippable unit of known composition, so a storefront works. Every category below this one gets progressively less transparent as the product gets less standard, and by the time you reach contractile tissue the published price count is zero.

Ready-to-use 3D tissue models

Living, metabolically active tissue that arrives ready to use. This category proves the hardest logistical part of the whole field is already routine — MatTek has been manufacturing human tissue centrally and mailing it to strangers on a weekly cadence for two decades.

Note the pattern. Every finished-tissue supplier in this category ships a fixed format. MatTek varies media composition, tissue variant and insert diameter, and will supply phenol-red-free, antibiotic-free and hydrocortisone-free variants — but it will not vary the shape. MIMETAS ships tissue in its own plate. InSphero ships spheroids. If your requirement has a geometry in it, this category cannot serve you and you are in the next one.

Engineered contractile tissue

The category with the clearest finding in the whole directory: no organisation surveyed sells a finished, force-specified, mechanically anchored muscle component as a catalogue item. Not one. What exists is (a) empty casting plasticware you fill yourself, (b) fee-for-service programmes that build the tissue as an intermediate step and sell you the resulting report, and (c) CROs that will quote a custom model as a development project.

The requirement is not exotic. Published data from a commercial platform reports engineered muscle tissue twitch forces in the hundreds of micronewtons rising past a millinewton with maturation, on tissues cast in a standard 24-well plate. What does not exist is anyone who will integrate the cell source, the mould, the casting, the maturation and the force test and hand you the physical object with an acceptance criterion attached. That integration gap is the reason this company exists, and we would rather state it than dress it up.

For the full treatment see engineered skeletal muscle tissue and the muscle actuator sourcing guide.

Neural cultures and electrode interfaces

Neurons delivered plated, matured and electrically interrogable, rather than as a frozen vial. The cells are catalogue items; the plating, the maturation and the MEA readiness are contract work, and nobody prices the combination.

If electrophysiology is your endpoint, the useful selection criterion is not price. It is whether the supplier’s published protocol names your instrument, because discovering a seeding density empirically costs several vials and several weeks. See MEA-ready neurons for what that phrase does and does not guarantee.

Culture devices, microfluidics and instruments

One published price in eight rows. The $440 OMEGA-MP figure matters far beyond its size, because it is the do-it-yourself price ceiling: any quote for a cast muscle tissue has to be justified against a customer who could buy the plate for $440 and seed it themselves. We use it as the reference point in the microfluidic device fabrication cost analysis.

Native and primary tissue to specification

Real animal and human tissue, collected and shipped against a written specification. Cheap, fast, and the correct answer whenever a passive mechanical part will do the job. This category also quietly proves that collect-to-spec is normal commercial practice rather than a favour.

Contract cell culture and manufacturing

Expansion, banking, cryopreservation, differentiation and process development, run on your cells or theirs. This is the category where GMP actually appears, and the only one where it does.

Nobody in this category publishes a rate card. Our reconstruction of what these services cost, built from the few published anchors that exist, is in contract cell culture and cell banking service cost.

QC, characterisation and acceptance testing

The independent test layer. If you are buying a component against a specification, somebody has to check it, and there is a real argument for that somebody not being the manufacturer.

What this category costs, including STR profiling and mycoplasma testing at the item level, is in cell QC testing cost, and what to insist on before a shipment leaves is in the cell supplier QC checklist.

Cold chain and logistics

There is no organisation in this directory that sells cold chain for engineered living tissue as a standalone service. Every supplier books its own carrier. That is a real constraint on multi-supplier orders, and it is why consolidating a shipment is usually harder than it sounds. See shipping live cells and tissue.

Exited, closed or discontinued

A directory that only records who is open is a directory that will send you an RFQ into a dead inbox. These two are the confirmed exits in this market, and both were plausible first calls until they were not.

The direction of travel matters. The obvious incumbents for a print-bureau model of tissue manufacture — a JLCPCB for living parts — both retreated from it within two years of each other. That is not proof the model cannot work, but anyone assuming the capability is sitting there waiting to be booked should know that it was tried at scale by a public company and stopped.

Two further organisations are live and well funded but should not receive an RFQ for a physical part, for a different reason: Vivodyne and Parallel Bio both run substantial living-tissue production, and both are vertically integrated around their own drug-discovery services. They sell data. Aspect Biosystems operates microfluidic bioprinting exclusively in service of its own implantable therapeutics pipeline. Xellar Biosystems sells organ-chip studies and model development rather than parts. Routing a component enquiry to any of these four wastes their time and yours.

How to use this directory

Start from the category, not the company. Almost every sourcing mistake we see starts with someone approaching a well-known name whose category does not contain the thing they need. MatTek is superb and cannot make you a muscle. Curi Bio has the deepest contractile muscle capability on the list and sells reports. Cook MyoSite has GMP muscle cells and does not build tissue.

Treat the price column as a market fact, not a supplier judgement. Publishing a price correlates with product standardisation, not with quality. The quote-only suppliers include several of the strongest organisations here.

Read the evidence column before you rely on a row. Four organisations in this directory blocked automated retrieval and are marked unverified. We have left them in because a lead you know is a lead is worth more than a silent omission, but do not put an unverified row into a procurement document without checking it yourself.

Assume RUO unless a row says otherwise. Three organisations in this entire directory make a GMP claim of any kind — Cook MyoSite for phase-appropriate GMP muscle cell manufacturing, Ncardia for GMP-ready manufacturing services, and FUJIFILM CDI in a separate product line to the research catalogue listed here. Everything else is research use only, and the distinction is explained in RUO vs GMP cells.

Ask about licensing before you ask about price. The terms attaching to derivatives are where the variance actually sits, they are never on the price list, and they are the thing that decides whether you can build a product on what you bought. See cell line licensing for commercial use.

Corrections and additions

We maintain this because we broker across it, not because anybody pays us to. If a row about your organisation is wrong, out of date, or describes a line of business you have discontinued, tell us and we will fix it and re-date the page — including removing you entirely if you would rather not be listed. Suppliers who want to be considered for sourcing requests should read what we send suppliers and what we expect back first, because the answer to “how do we get on the list” is that there is no list to buy onto.

If you are buying rather than selling, the fastest route is not to work down this table. Send the specification and we will source against it — request a quote — or read how we source to see exactly what happens to a request after it arrives.